Exposed proliferation antigen 210 (XPA-210) in renal cell carcinoma (RCC) and oncocytoma: clinical utility and biological implications (Q33944741)

From Wikidata

Revision as of 08:41, 9 August 2024 by Kpjas (talk | contribs) (‎Updated Item: Changing author name 'Arnulf Stenzl' to P50:Arnulf Stenzl (Q86981035) (via author_strings gadget))

(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Exposed proliferation antigen 210 (XPA-210) in renal cell carcinoma (RCC) and oncocytoma: clinical utility and biological implications	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Exposed proliferation antigen 210 (XPA-210) in renal cell carcinoma (RCC) and oncocytoma: clinical utility and biological implications (English)

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

renal cell carcinoma

1 reference

based on heuristic

inferred from title

object named as

Stephan Kruck

1

0 references

8

object named as

Arnulf Stenzl

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

author name string

Joerg Hennenlotter

2

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Ulrich Vogel

3

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

David Schilling

4

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Georgios Gakis

5

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Joachim Hevler

6

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Ursula Kuehs

7

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Christian Schwentner

9

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

publication date

28 June 2011

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

BJU International

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

109

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

634-638

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Renal cell carcinoma guideline

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10392.X

21 January 2018

An update on the medical therapy of advanced metastatic renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10392.X

21 January 2018

Thymidine kinase 1 is a potential marker for prognosis and monitoring the response to treatment of patients with breast, lung, and esophageal cancer and non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10392.X

21 January 2018

Serum deoxythymidine kinase in small cell carcinoma of the lung. Relation to clinical features, prognosis, and other biochemical markers

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10392.X

21 January 2018

The proliferation marker thymidine kinase 1 level is high in normal kidney tubule cells compared to other normal and malignant renal cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10392.X

21 January 2018

Mitotic degradation of human thymidine kinase 1 is dependent on the anaphase-promoting complex/cyclosome-CDH1-mediated pathway

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10392.X

21 January 2018

Serum thymidine kinase 1 correlates to clinical stages and clinical reactions and monitors the outcome of therapy of 1,247 cancer patients in routine clinical settings

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10392.X

21 January 2018

High serum thymidine kinase 1 level predicts poorer survival in patients with chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10392.X

21 January 2018

Circulating tumor M2 pyruvate kinase and thymidine kinase 1 are potential predictors for disease recurrence in renal cell carcinoma after nephrectomy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10392.X

21 January 2018

Thymidine kinase activity in serum of renal cell carcinoma patients is a useful prognostic marker

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10392.X

21 January 2018

Production and characterisation of a novel chicken IgY antibody raised against C-terminal peptide from human thymidine kinase 1.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10392.X

21 January 2018

Specific recognition of cytosolic thymidine kinase in the human lung tumor by monoclonal antibodies raised against recombinant human thymidine kinase

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10392.X

21 January 2018

Investigation on cell proliferation with a new antibody against thymidine kinase 1

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10392.X

21 January 2018

A comparative study: immunohistochemical detection of cytosolic thymidine kinase and proliferating cell nuclear antigen in breast cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10392.X

21 January 2018

Identifiers

10.1111/J.1464-410X.2011.10392.X

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33944741&oldid=2223688942"